Olema Oncology partners with Pfizer for breast cancer drug trial
Go back to Olema Oncology partners with Pfizer for breast cancer drug trial| (NASDAQ: OLMA) | Delayed: 10.75 -0.08 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.83 | 52 Week High | $ | |||
| Open | $10.71 | 52 Week Low | $ | |||
| Day High | $10.98 | P/E | N/A | |||
| Day Low | $10.59 | EPS | $ | |||
| Volume | 162,311 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.67 -0.35 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.02 | 52 Week High | $37.39 | |||
| Open | $29.09 | 52 Week Low | $28.25 | |||
| Day High | $29.21 | P/E | 17.38 | |||
| Day Low | $28.44 | EPS | $1.65 | |||
| Volume | 9,321,068 | |||||

